Prognostic indicators are typically assessed through a combination of histopathological techniques, including microscopic examination, immunohistochemistry, and molecular testing. Tissue samples are stained and analyzed to identify specific markers and cellular characteristics. Advances in technology have also enabled the use of genomic profiling and other molecular assays to provide a more comprehensive understanding of a patient's prognosis.
